Literature DB >> 27342423

Alcohol and fat promote steatohepatitis: a critical role for fat-specific protein 27/CIDEC.

Suthat Liangpunsakul1, Bin Gao2.   

Abstract

Alcoholic liver disease (ALD) is a major public health problem worldwide and is the leading cause of end-stage liver disease. While the ultimate control of ALD will require the prevention of alcohol abuse, better understanding of the mechanisms of alcohol-induced liver injury may lead to treatments of fatty liver, alcoholic hepatitis, and prevention or delay of occurrence of cirrhosis. The elucidation and the discovery of several new concepts in ALD pathogenesis have raised our understanding on the complex mechanisms and the potential in developing the new strategies for therapeutic benefits. In this review, we provide the most up-to-date information on the basic molecular mechanisms focusing on the role of fat-specific protein 27/CIDEC in the pathogenesis of ALD.
Copyright © 2016 American Federation for Medical Research.

Entities:  

Keywords:  Fatty Liver; Liver Diseases, Alcoholic

Mesh:

Substances:

Year:  2016        PMID: 27342423      PMCID: PMC4972581          DOI: 10.1136/jim-2016-000204

Source DB:  PubMed          Journal:  J Investig Med        ISSN: 1081-5589            Impact factor:   2.895


  34 in total

1.  Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression.

Authors:  Songtao Yu; Kimihiko Matsusue; Papreddy Kashireddy; Wen-Qing Cao; Vaishalee Yeldandi; Anjana V Yeldandi; M Sambasiva Rao; Frank J Gonzalez; Janardan K Reddy
Journal:  J Biol Chem       Date:  2002-10-24       Impact factor: 5.157

2.  Transcriptional activation of Fsp27 by the liver-enriched transcription factor CREBH promotes lipid droplet growth and hepatic steatosis.

Authors:  Xu Xu; Jong-Gil Park; Jae-Seon So; Ann-Hwee Lee
Journal:  Hepatology       Date:  2015-01-28       Impact factor: 17.425

3.  Fat-specific protein 27 modulates nuclear factor of activated T cells 5 and the cellular response to stress.

Authors:  Masami Ueno; Wen-Jun Shen; Shailja Patel; Andrew S Greenberg; Salman Azhar; Fredric B Kraemer
Journal:  J Lipid Res       Date:  2012-12-11       Impact factor: 5.922

4.  Synergistic steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p-AMPK.

Authors:  Jun Xu; Keane K Y Lai; Alla Verlinsky; Aurelia Lugea; Samuel W French; Marcus P Cooper; Cheng Ji; Hidekazu Tsukamoto
Journal:  J Hepatol       Date:  2011-01-21       Impact factor: 25.083

Review 5.  Role of fatty acids in the pathogenesis of insulin resistance and NIDDM.

Authors:  G Boden
Journal:  Diabetes       Date:  1997-01       Impact factor: 9.461

6.  Cloning and transcriptional regulation of a novel adipocyte-specific gene, FSP27. CAAT-enhancer-binding protein (C/EBP) and C/EBP-like proteins interact with sequences required for differentiation-dependent expression.

Authors:  U Danesch; W Hoeck; G M Ringold
Journal:  J Biol Chem       Date:  1992-04-05       Impact factor: 5.157

Review 7.  CIDE proteins and metabolic disorders.

Authors:  Jingyi Gong; Zhiqi Sun; Peng Li
Journal:  Curr Opin Lipidol       Date:  2009-04       Impact factor: 4.776

8.  Fat-specific protein 27 inhibits lipolysis by facilitating the inhibitory effect of transcription factor Egr1 on transcription of adipose triglyceride lipase.

Authors:  Maneet Singh; Rajween Kaur; Mi-Jeong Lee; R Taylor Pickering; Vishva Mitra Sharma; Vishwajeet Puri; Konstantin V Kandror
Journal:  J Biol Chem       Date:  2014-04-17       Impact factor: 5.157

9.  CCAAT/enhancer binding protein expression is rapidly extinguished in TA1 adipocyte cells treated with tumor necrosis factor.

Authors:  P M Williams; D J Chang; U Danesch; G M Ringold; R A Heller
Journal:  Mol Endocrinol       Date:  1992-07

10.  Fat-specific protein 27 (FSP27) interacts with adipose triglyceride lipase (ATGL) to regulate lipolysis and insulin sensitivity in human adipocytes.

Authors:  Tan Hooi Min Grahn; Rajween Kaur; Jun Yin; Martina Schweiger; Vishva Mitra Sharma; Mi-Jeong Lee; Yasuo Ido; Cynthia M Smas; Rudolf Zechner; Achim Lass; Vishwajeet Puri
Journal:  J Biol Chem       Date:  2014-03-13       Impact factor: 5.157

View more
  4 in total

1.  Inflammation is independent of steatosis in a murine model of steatohepatitis.

Authors:  Wei Wang; Ming-Jiang Xu; Yan Cai; Zhou Zhou; Haixia Cao; Partha Mukhopadhyay; Pal Pacher; Shusen Zheng; Frank J Gonzalez; Bin Gao
Journal:  Hepatology       Date:  2017-05-18       Impact factor: 17.425

2.  Hepatic stellate cell activation promotes alcohol-induced steatohepatitis through Igfbp3 and SerpinA12.

Authors:  Juan P Arab; Daniel Cabrera; Tejasav S Sehrawat; Nidhi Jalan-Sakrikar; Vikas K Verma; Douglas Simonetto; Sheng Cao; Usman Yaqoob; Jonathan Leon; Mariela Freire; Jose I Vargas; Thiago M De Assuncao; Jung H Kwon; Yi Guo; Enis Kostallari; Qing Cai; Tatiana Kisseleva; Youngman Oh; Marco Arrese; Robert C Huebert; Vijay H Shah
Journal:  J Hepatol       Date:  2020-02-20       Impact factor: 25.083

3.  CIDEC silencing attenuates diabetic nephropathy via inhibiting apoptosis and promoting autophagy.

Authors:  Gao-Shu Zheng; Yan-Min Tan; Yuan-Yuan Shang; Ya-Peng Liu; Bo-Ang Hu; Di Wang; Lu Han; Zhi-Hao Wang; Wei Zhang; Yun Ti; Ming Zhong
Journal:  J Diabetes Investig       Date:  2021-08       Impact factor: 4.232

4.  ATF4 activation promotes hepatic mitochondrial dysfunction by repressing NRF1-TFAM signalling in alcoholic steatohepatitis.

Authors:  Liuyi Hao; Wei Zhong; Haibo Dong; Wei Guo; Xinguo Sun; Wenliang Zhang; Ruichao Yue; Tianjiao Li; Alexandra Griffiths; Ali Reza Ahmadi; Zhaoli Sun; Zhenyuan Song; Zhanxiang Zhou
Journal:  Gut       Date:  2020-11-11       Impact factor: 23.059

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.